Sebastián Ibáñez Vodnizza, MD (he/him/his)

Clínica Alemana de Santiago
Santiago, Chile

Special interest Spondyloarthritis and psoriatic arthritis

Presentation(s):

• 2154: Two-Year Persistence of First-Line Biological or JAK Inhibitor Treatment in Patients with Long-Standing Rheumatoid Arthritis and Failure of Triple Therapy with Synthetic DMARDs

  Tuesday, November 14, 2023
  9:00 AM – 11:00 AM PT

  Disclosure information not submitted.